Annual report pursuant to Section 13 and 15(d)

Segment Information (Details) - Schedule of segment reporting information

v3.22.1
Segment Information (Details) - Schedule of segment reporting information - USD ($)
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Revenues    
Revenues $ 1,390,972 $ 1,377,762
Costs and expenses    
Costs and expenses 976,454 987,559
Gross profit    
Gross profit 414,518 390,203
Other operating expenses    
Other operating expenses 9,248,348 12,844,222
Interest expense    
Interest expense (200,477) (168,762)
Other income (expense)    
Other income (expense) (56,192) (56,657)
Total other expense, net (256,669) (225,419)
Net loss    
Net income (loss) 9,090,499 12,679,438
Real Property Operations [Member]    
Revenues    
Revenues 1,203,560 1,206,854
Costs and expenses    
Costs and expenses 829,287 851,754
Gross profit    
Gross profit 374,273 355,100
Other operating expenses    
Other operating expenses 381,266 418,863
Other income (expense)    
Other income (expense) 115 (921)
Net loss    
Net income (loss) 6,878 64,684
Medical Related Consulting Services [Member]    
Revenues    
Revenues 187,412 170,908
Costs and expenses    
Costs and expenses 147,167 135,805
Gross profit    
Gross profit 40,245 35,103
Other operating expenses    
Other operating expenses 469,942 577,962
Other income (expense)    
Other income (expense) (61,494) (55,964)
Net loss    
Net income (loss) 491,191 598,823
Development Services and Sales of Developed Products [Member]    
Other operating expenses    
Other operating expenses 123,546
Other income (expense)    
Other income (expense) 228
Net loss    
Net income (loss) 123,318
Corporate/Other [Member]    
Other operating expenses    
Other operating expenses 8,397,140 11,723,851
Interest expense    
Interest expense (200,477) (168,762)
Other income (expense)    
Other income (expense) 5,187
Net loss    
Net income (loss) $ 8,592,430 $ 11,892,613